Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
Pre-Market: 20:00
Dynavax Technologies Enterprise Value: 1.084B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.084B |
| November 20, 2024 | 1.059B |
| November 19, 2024 | 1.038B |
| November 18, 2024 | 996.27M |
| November 15, 2024 | 1.065B |
| November 14, 2024 | 1.220B |
| November 13, 2024 | 1.237B |
| November 12, 2024 | 1.234B |
| November 11, 2024 | 1.255B |
| November 08, 2024 | 1.170B |
| November 07, 2024 | 1.040B |
| November 06, 2024 | 1.075B |
| November 05, 2024 | 1.038B |
| November 04, 2024 | 1.008B |
| November 01, 2024 | 1.007B |
| October 31, 2024 | 1.016B |
| October 30, 2024 | 1.044B |
| October 29, 2024 | 1.011B |
| October 28, 2024 | 955.59M |
| October 25, 2024 | 866.27M |
| October 24, 2024 | 874.15M |
| October 23, 2024 | 887.29M |
| October 22, 2024 | 903.05M |
| October 21, 2024 | 901.74M |
| October 18, 2024 | 897.80M |
| Date | Value |
|---|---|
| October 17, 2024 | 893.86M |
| October 16, 2024 | 908.30M |
| October 15, 2024 | 872.84M |
| October 14, 2024 | 833.44M |
| October 11, 2024 | 829.50M |
| October 10, 2024 | 809.80M |
| October 09, 2024 | 850.51M |
| October 08, 2024 | 855.77M |
| October 07, 2024 | 874.15M |
| October 04, 2024 | 906.99M |
| October 03, 2024 | 929.32M |
| October 02, 2024 | 950.33M |
| October 01, 2024 | 943.77M |
| September 30, 2024 | 922.75M |
| September 27, 2024 | 929.15M |
| September 26, 2024 | 909.49M |
| September 25, 2024 | 899.01M |
| September 24, 2024 | 912.11M |
| September 23, 2024 | 943.56M |
| September 20, 2024 | 975.01M |
| September 19, 2024 | 994.67M |
| September 18, 2024 | 956.67M |
| September 17, 2024 | 963.22M |
| September 16, 2024 | 948.81M |
| September 13, 2024 | 951.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
223.19M
Minimum
Mar 16 2020
2.318B
Maximum
Nov 03 2021
1.032B
Average
1.033B
Median
Sep 28 2022
Enterprise Value Benchmarks
| Biogen Inc | 27.62B |
| Repligen Corp | 7.680B |
| West Pharmaceutical Services Inc | 22.95B |
| Janux Therapeutics Inc | 1.782B |
| XOMA Royalty Corp | 329.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.59M |
| Revenue (Quarterly) | 80.63M |
| Total Expenses (Quarterly) | 70.55M |
| EPS Diluted (Quarterly) | 0.12 |
| Gross Profit Margin (Quarterly) | 83.77% |
| Profit Margin (Quarterly) | 21.82% |
| Earnings Yield | 1.05% |
| Normalized Earnings Yield | 1.052 |